Rankings
▼
Calendar
AMRN Q4 2016 Earnings — Amarin Corporation plc Revenue & Financial Results | Market Cap Arena
AMRN
Amarin Corporation plc
$335M
Q4 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$39M
Gross Profit
$29M
73.8% margin
Operating Income
-$13M
-33.2% margin
Net Income
-$27M
-70.9% margin
EPS (Diluted)
$-2.04
QoQ Revenue Growth
+18.2%
Cash Flow
Operating Cash Flow
-$19M
Free Cash Flow
-$19M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$167M
Total Liabilities
$176M
Stockholders' Equity
-$9M
Cash & Equivalents
$98M
← FY 2016
All Quarters
Q1 2017 →